Merck Expands Stonewall Plant for Gardasil Production

Published March 2007

ELKTON, VA. -

Merck is engaged in a $57-million expansion of its Stonewall plant in Elkton, Va. to accommodate demand for its Gardasil vaccine. The project is the second phase of expansion at the facility and includes construction of a new building and installation of purification technologies for pharmaceutical production. The first $40-million phase included a vaccine fermentation unit and was completed in 2006.

 

Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894